FDA Inspection 1178335 — Antria, Inc.
The FDA completed an inspection of Antria, Inc. on Aug 12, 2022 in Indiana, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 12, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Indiana, PA (United States)
Additional details
Sponsor, Contract Research Organization